The move places eTrinsic in one of the most vibrant and popular areas of the city, offering greater access to a broad range of talent.

Thursday, Jun 1, 2006 5:00 AM

Cleveland, OH and Denver, CO: eTrinsic, a division of Simbionix USA, a leading developer of online education and training products serving the medical device industry and medical education sectors, has relocated their offices from Louisville, Colorado to the historical LoDo district of Denver, Colorado.

The move places eTrinsic in one of the most vibrant and popular areas of the city, offering greater access to a broad range of talent.

Jacques Devaud, President, stated, Moving to Denver, and especially to a central, highly accessible and popular area, will make it easier for eTrinsic to attract and retain the best class of employee.

This is important as we grow to accomplish our business goals.

Gary Zamler, Simbionix CEO, added "The investment in our division's new office facility serves as an example of our expanded commitment to the important US market, our comprehensive Content & Education product strategy, and our confidence in eTrinsic's ability to implement this strategy.

We want to remain the world leader in the field of medical education and simulation technology, and to continue to offer the most comprehensive medical training experience available, using the latest software and hardware technology."

eTrinsic, a division of Simbionix USA., is the leading developer of e-learning content and proficiency measurement technology exclusively for the medical sector, with primary focus on developing web-enabled simulations of highly complex medical devices, equipment, and procedures.

eTrinsic brings deep medical domain expertise to each project, along with seasoned development and technology teams.

Simbionix is a global leader in medical simulation technology.

The company's mission is to provide state of the art, simulation-based medical education and training systems, and to set the standard for minimally invasive procedural training and performance measurement.

Since the successful introduction of the GI Mentor™ to the world market in 2000, Simbionix has completed four other medical training simulators, which provide medical experts with hands-on training in a comprehensive array of Minimally Invasive procedures; the URO Mentor™ – a simulator for endourology procedures, the PERC Mentor™ for percutaneous access procedures, the LAP Mentor™ – a multi disciplinary simulator for laparoscopic skills and surgery procedures, and the recently launched and enthusiastically received ANGIO Mentor™ for interventional cardiologists, interventional radiologists and vascular surgeons.

All the Mentor line of products can be used to perform complete procedures, as well to acquire basic skills.

Early Stage Partners LP is the most active early stage venture capital fund based in Cleveland, Ohio.

Early Stage Partners was formed to fill an unserved market need in financing the commercialization of world-class technologies.

The company invests primarily in promising opportunities in the life sciences; enterprise software, supply chain management, polymers and advanced materials.

Koor Corporate Venture Capital, (NYSE:KOR, TASE) is the venture capital arm of Koor Industries – one of the Israel's largest investment-holding company ($1 billion).

KVC invests in the areas of telecommunications technology, internet infrastructure, enterprise software and life sciences.

Shestra (Switzerland), one of the earliest investors in Simbionix.

is a Geneva-based private equity banking group.